ASSESSMENT OF THE DYNAMICS OF THE FUNCTIONAL STATE OF POST-STROKE PATIENTS WITH SPASTIC HEMIPARESIS IN THE COURSE OF REHABILITATION INTERVENTIONS



Cite item

Full Text

Abstract

The article describes the assessment of the dynamics of the functional state of post-stroke 62 patients with spastic hemiparesis in the course of rehabilitational interventions (Group 1) and a combination of rehabilitational interventions and botulinum therapy (Group 2). A positive dynamics of the functional state was revealed in both patient groups. However, a reduction in the level of spasticity and an amelioration of the functioning of paretic extremities were more significant in the patient group treated with botulotoxinum type A.

About the authors

Vladimir A Mikhailov

St. Petersburg V.M. Bekhterev research psychoneurology Institute

Email: 79112150910@ya.ru
192019, St. Petersburg, Bekhterev street, 3

Denis V Zakharov

St. Petersburg V.M. Bekhterev research psychoneurology Institute

Email: 79112150910@ya.ru
192019, St. Petersburg, Bekhterev street, 3

Julia I Dyagileva

St. Petersburg V.M. Bekhterev research psychoneurology Institute

Email: 79112150910@ya.ru
192019, St. Petersburg, Bekhterev street, 3

References

  1. Гусев Е.И., Скворцова Е.И., Стаховская Л.В. и др. Эпидемиология инсульта в России // Consilium medicum, журнал доказательной медицины для практикующих врачей, специальный выпуск. - Проблемы цереброваскулярной патологии и инсульта. 2003. С. 5-7.
  2. Захаров Д.В., Балунов О.А. Динамика показателей функционального состояния и качества жизни у пациентов с дисциркуляторной энцефалопатией в процессе лечения // Обозрение психиатрии и медицинской психологии им. В.М. Бехтерева. 2007. Т. 4, № 2. С. 10-12.
  3. Кадыков А. С., Черникова Л. А., Шахпаронова Н.В. Реабилитация неврологических больных. М.: Медпресс-информ. 2009. 560 с.
  4. Ashford S., Turner-Stokes L. Goal attainment for spasticity management using botulinum toxin // Physiother Res Int. 2006. Vol. 11. P. 24-34.
  5. Bakheit A.M., Pittock S., Moore A.P. et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke // Eur. J. Neurol. 2001. Vol. 8. P. 559-565.
  6. Bakheit A.M., Thilmann A.F., Ward A.B. et al. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke // Stroke. 2000. Vol. 31. P. 2402-2406.
  7. Bayram S., Sivrioglu K., Karli N., Ozcan O. Low-dose botulinum toxin with short-term electrical stimulation in poststroke spastic drop foot: a preliminary study // Am. J. Phys. Med. Rehabil. 2006. Vol. 85. P. 75-81.
  8. Bleyenheuft C., Cockx S., Caty G. et al. The effect of botulinum toxin injections on gait control in spastic stroke patients presenting with a stiff-knee gait// Gait and Posture. 2009. Vol. 30 (2). P. 168-172.
  9. Brock K., Black S., Cotton S. et al. Goal achievement in the six months after inpatient rehabilitation for stroke // Disabil Rehabil. 2009. Vol. 31. P. 880-886.
  10. Childers M.K., Brashear A., Jozefczyk P. et al. Dose-dependent response to intramuscular botulinum toxin type A for upper- limb spasticity in patients after a stroke // Arch. Phys. Med. Rehabil. 2004. Vol. 85. P. 1063-1069.
  11. De Boer K.S., Arwert H.J., De Groot J.H. et al. Shoulder pain and external rotation in spastic hemiplegia do not improve by injection of botulinum toxin A into the subscapular muscle // J. Neurol. Neurosurg. Psychiatry. 2008. Vol. 79. P. 581-583.
  12. Doan Q.V., Brashear A., Gillard P.J. et al. Relationship between disability and health- related quality of life and caregiver burden in patients with upper limb poststroke spasticity // Polymyalgia Rheumatica. 2012. Vol. 4. P. 4-10.
  13. Elia A.E., Filippini G., Calandrella D., Albanese A. Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review // Mov. Disord. 2009. Vol. 24. P. 801-812.
  14. Elovic E.P., Brashear A., Kaelin D. et al. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients // Arch. Phys. Med. Rehabil. 2008. Vol. 89. P. 799-806.
  15. Francis H.P., Wade D.T., Turner-Stokes L. et al. Does reducing spasticity translate into functional benefit? An exploratory meta-analysis // J. Neurol. Neurosurg. Psychiatry. 2004. Vol. 75. P. 1547-1551.
  16. Jahangir A.W., Tan H.J., Norlinah M.I. et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke // Med. J. Malaysia. 2007. Vol. 62. P. 319-322.
  17. Kaji R., Osako Y., Suyama K. et al. Botulinum toxin type A in post-stroke upper limb spasticity // Curr. Med. Res. Opin. 2010. Vol. 26. P. 1983-1992.
  18. Kong K.H., Neo J.J., Chua K.S. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity // Clin. Rehabil. 2007. Vol. 21. P. 28-35.
  19. Lance J.W. The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture // Neurology. 1980. Vol. 30, № 12. P. 1303-1313.
  20. Mancini F., Sandrini G., Moglia A. et al. A randomised, double-blind, dose- ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot // Neurol Sci. 2005. Vol. 26. P. 26-31.
  21. McCrory P., Turner-Stokes L., Baguley I.J. et al. Botulinum toxin A for treatment of upper limb spasticity following stroke: A multicentre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes // Journal of Rehabilitation Medicine. 2009. Vol. 41. P. 536-544.
  22. Meythaler J.M., Vogtle L., Brunner R.C. A preliminary assessment of the benefits of the addition of botulinum toxin a to a conventional therapy program on the function of people with longstanding stroke // Arch. Phys. Med. Rehabil. 2009. Vol. 90. P. 1453-1461.
  23. Pittock S.J., Moore A.P., Hardiman O. et al. A double- blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke // Cerebrovasc Dis. 2003. Vol. 15. P. 289-300.
  24. Royal College of physicians, the Intercollegiate Stroke Working party. National clinical guideline for stroke. Third edition. London: RCp, 2008.
  25. Simpson D.M., Gracies J.M., Graham K., et al. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review) // Neurology. 2009. Vol. 73. P. 736-737; author reply 737-738.
  26. Shaw L.C., Price C.I., Van Wijck F.M. et al. Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain // Stroke. 2011. Vol. 42. P. 1371-1379.
  27. Suputtitada A., Suwanwela N.C. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity // Disabil Rehabil. 2005. Vol. 27. P. 176-184.
  28. Van Kuijk A.A., Geurts A.C., Bevaart B.J., van Limbeek J. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature // J. Rehabil. Med. 2002. Vol. 34. P. 51-61.
  29. Yelnik A.P., Colle F.M., Bonan I.V., Vicaut E. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A // J. Neurol. Neurosurg. Psychiatry. 2007. Vol. 78. P. 845-848.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Mikhailov V.A., Zakharov D.V., Dyagileva J.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 75562 от 12 апреля 2019 года.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies